TradingAgents AISign inGet started
All stock profiles
ARAYNASDAQHealthcare

ACCURAY INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$0.11

-11.22%

Alpha Vantage · 11/6/2026

Industry: Medical DevicesCategory: Domestic Common StockCurrency: USDNews: 1 recent
Analyze ARAY free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

-54.4%

3 months

-62.3%

6 months

-71.0%

1 year

-91.0%

Year to date

-86.7%

52-week range

$0.11 – $1.22

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$13.1M

P/E

-0.3

P/B

0.3

P/S

0

Revenue

$401.95M

Net income

-$49.19M

Diluted EPS

-0.4

Gross margin

27.70%

Net margin

-12.20%

Return on equity

-99.00%

Total debt

$183.87M

Cash

$48.77M

Free cash flow

-$19.26M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$100.92M-$1.94M34.80%-1.90%$1.07M
Mar 31, 2026$104.85M-$11.81M24.10%-11.30%-$7.11M
Dec 31, 2025$102.24M-$13.77M23.50%-13.50%-$21.58M
Sep 30, 2025$93.94M-$21.68M28.30%-23.10%$8.36M
Jun 30, 2025$127.54M$1.12M30.60%0.90%-$13.11M
Mar 31, 2025$113.24M-$1.3M27.90%-1.10%$15.63M
Dec 31, 2024$116.17M$2.54M36.10%2.20%$231K
Sep 30, 2024$101.55M-$3.95M33.90%-3.90%-$8.41M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent ARAY news

All market news
scanx.trade·60 signal
Accuray Q1FY27 Results: Revenue down 8% YoY as China headwinds persist

Accuray reported an 8% year-over-year decline in net revenue to $86.5 million for Q1 FY27, primarily due to geopolitical challenges in China. Despite this, the company achieved a positive adjusted EBITDA of $2.5 million, a significant improvement from a $4.1 million loss in the prior year, driven by a 4% increase in service revenue and a 25% reduction in operating expenses. Product revenue fell 26%, and the book-to-bill ratio of 0.7 indicates ongoing pressure on future hardware sales.

Original source